SBMU Journals
  • Register
  • Login

Archives of Men's Health

  • Home
  • About
    • AMH Policies
    • Editorial Team
    • Contact
  • Issues
    • Current
    • Archives
  • Indexing and Abstracting
  • For Reviewers
    • Peer review process
    • Peer Review Policy
    • Reviewer guideline
  • For Authors
    • Submissions
    • Author Guidelines
    • Article Withdrawal Policy
    • Peer Review Process
    • Frequently Asked Questions (FAQ)
  • Ethical Consideration
    • Ethical Requirements
    • Plagiarism Policy
    • Authorship Conflicts
    • Malpractice Statements
    • Copyright Notice
    • Intellectual Property Policy
    • Privacy Statement
    • Artificial Intelligence & Authorship
    • Retraction Policy
Advanced Search
  1. Home
  2. Archives
  3. Vol. 3 No. 1 (2019)
  4. Original Article / Research Article

Vol. 3 No. 1 (2019)

April 2019

Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) in Shohada Tajrish Hospital

  • Hoda Hashemi
  • Fereshteh Aliakbari
  • Samira shariatpanahi
  • Reza Hashemi

Archives of Men's Health, Vol. 3 No. 1 (2019), 13 April 2019 , Page e16
https://doi.org/10.22037/mhj.v3i1.33121 Published: 2020-12-05

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Introduction: This paper aims to determine the effectiveness and sensitivity of peak expiratory flow in early diagnosis of chronic obstructive pulmonary disease (COPD). In view of high cost and unavailability of spirometry and the ever-increasing prevalence of COPD as a result of cigarette smoking, this study can do much to lighten the economic burden in national health system. Materials and Methods: We examined 250 patients taking spirometry test in Shohadaye Tajrish Hospital during 2008, chosen by simple random sampling method. COPD was defined as FEV/FVC<70% according to existing resources. PEF values smaller than 80% were considered as abnormal based on ATS criteria. We assessed PEF sensitivity in comparison with FEV1/FVC. Results: COPD prevalence among spirometry tests was 21.2%. Out of the patients, 76.27% were male and 92.9% were older than 40. PEF sensitivity was 74% and its specificity was 97.5%.  Discussion: The higher COPD prevalence among men may be explained by higher cigarette smoking rate among men than in women in our country. Moreover, COPD occurrence risk increases with age. Conclusion: The positive predictive value of PEF compared with EFV1/FVC reveals that this test is an appropriate diagnostic tool which can diagnose COPD earlier than EFV1/FVC.

  • pdf

How to Cite

Hashemi, H., Aliakbari, F., shariatpanahi, S., & Hashemi, R. (2020). Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) in Shohada Tajrish Hospital. Archives of Men’s Health, 3(1), e16. https://doi.org/10.22037/mhj.v3i1.33121
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine, 19e: Mcgraw-hill; 2015.

Quaderi S, Hurst J. The unmet global burden of COPD. Global health, epidemiology and genomics. 2018;3.

Anderson NM. CECIL'S TEXTBOOK OF MEDICINE. Prehospital Emergency Care. 2005;9(1):100.

Clini E, Holland AE, Pitta F, Troosters T. Textbook of pulmonary rehabilitation: Springer; 2018.

Mahmood T, Singh RK, Kant S, Shukla AD, Chandra A, Srivastava RK. Prevalence and etiological profile of chronic obstructive pulmonary disease in nonsmokers. Lung India: Official Organ of Indian Chest Society. 2017;34(2):122.

Jindal S. Textbook of Pulmonary and Critical Care Medicine: Two Volume Set: JP Medical Ltd; 2017.

Maddocks M, Lovell N, Booth S, Man WD, Higginson IJ. Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease. The Lancet. 2017;390(10098):988-1002.

Ko FW, Chan KP, Hui DS, Goddard JR, Shaw JG, Reid DW, et al. Acute exacerbation of COPD. Respirology. 2016;21(7):1152-65.

Collaborators GCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine. 2017;5(9):691.

Piazzolla G, Castrovilli A, Liotino V, Vulpi MR, Fanelli M, Mazzocca A, et al. Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D. PLoS One. 2017;12(10):e0186708.

Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. The Lancet. 2018;391(10131):1706-17.

Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma? American journal of respiratory and critical care medicine. 1995;151(5):1320-5.

Gulla KM, Kabra S. Peak expiratory flow rate as a monitoring tool in asthma. The Indian Journal of Pediatrics. 2017;84(8):573-4.

Thorat YT, Salvi SS, Kodgule RR. Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study. NPJ primary care respiratory medicine. 2017;27(1):1-7.

Domingos Neto J, Myung E, Murta G, Lima PR, Vieira A, Lessa LA, et al. Asthma and occupation: Diagnosis using serial peak flow measurements. Revista da Associação Médica Brasileira. 2018;64(2):95-9.

Dobra R, Equi A. How to use peak expiratory flow rate. Archives of Disease in Childhood-Education and Practice. 2018;103(3):158-62.

Nair S, Padmanabhan A, Kumari A. Peak-flow or portable spirometry as a replacement for Spirometry in the diagnosis of COPD and Asthma. Eur Respiratory Soc; 2018.

Shilpa N, Veena H. Peak flow meter and digital spirometer: A comparative study of peak expiratory flow rate values. National Journal of Physiology, Pharmacy and Pharmacology. 2020;10(6):1-3.

Carpenter DM, Jurdi R, Roberts CA, Hernandez M, Horne R, Chan A. A review of portable electronic spirometers: implications for asthma self-management. Current allergy and asthma reports. 2018;18(10):53.

Myatt R. Measuring peak expiratory flow rate: what the nurse needs to know. Nursing Standard. 2017;31(20):40-4.

Klingman KJ, Castner J, Titus AH. A review of worldwide patents: Innovations in peak flow meters for asthma. Nursing Research. 2016;65(3):238-48.

Kelly C, Gibson G. Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax. 1988;43(4):335.

Lebowitz MD, Knudson RJ, Robertson G, Burrows B. Significance of intraindividual changes in maximum expiratory flow volume and peak expiratory flow measurements. Chest. 1982;81(5):566-70.

Thiadens H, De Bock G, Van Houwelingen J, Dekker F, De Waal M, Springer M, et al. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV1 in primary care patients presenting with a persistent cough? Thorax. 1999;54(12):1055-60.

White P. COPD: Challenges and opportunities for primary care. Respiratory Medicine: COPD Update. 2005;1(2):43-52.

Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory research. 2010;11(1):122.

Aggarwal AN, Agarwal R, Gupta D, Jindal SK. Use of peak expiratory flow for assessing bronchodilator responsiveness. Primary Care Respiratory Journal. 2009;18(1):50-2.

  • Abstract Viewed: 320 times
  • pdf Downloaded: 240 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Make a Submission

Make a Submission

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians

Browse

  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

This journal is distributed under the terms of CC BY-NC 3.0. Design and publishing by SBMU journals. All credits and honors to PKP for their OJS. 

Powered by OJSPlus